Nuclear Medicine Clinical Trial Group, LLC (NMCTG)

In September 2008, the Society of Nuclear Medicine and Molecular Imaging created the Nuclear Medicine Clinical Trial Group, LLC to assist sponsors in effectively incorporating molecular imaging agents in multicenter trials.  NMCTG aims to ensure that high-quality imaging is conducted to support drug or diagnostic clinical studies by offering a variety of proven tools developed by the Clinical Trials Network. 

  • Education and training for molecular imaging professionals performing clinical research
  • Robust PET scanner validation program to ensure scanner stability at individual study sites and help standardize PET imaging across sites in a study
  • Secure central image and data management platform
  • Auditing of radiopharmaceutical manufacturing sites to ensure the safety of study patients by monitoring production of the investigational imaging agent being used


Gallium DOTATOC Image Interpretation Training

Click here to download the training powerpoint slides

Support for the development of this educational presentation generously provided by the Margie & Robert E. Petersen Foundation.

Disclaimer: The above course and any material it contains, including but not limited to texts, data, graphics, pictures, sounds, videos, logos, icons and html-code, are protected. Any other use in any form and by any means (such as but not limited to reproduction, distribution, sales, publication, modification, translation, use for commercial purposes) of the content of the course is prohibited without prior written consent of University of Iowa and NMCTG, LLC. 

UPDATED! AxuminTM Image Interpretation Training 

Click here to enter the Interpretation Training. 

Click here to find out whats's new in the module.

AxuminTM DICOM Cases 

Click here to download instructions and view the DICOM cases



NMCTG Structure